Compounds > 3,4-dihydroxyphenylacetaldehyde
Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and homovanillic acid

3,4-dihydroxyphenylacetaldehyde has been researched along with homovanillic acid in 4 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)		Trials
(3,4-dihydroxyphenylacetaldehyde)		Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)		Studies
(homovanillic acid)		Trials
(homovanillic acid)		Recent Studies (post-2010) (homovanillic acid)
990506,127312438

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eisenhofer, G; Harvey-White, J; Hayakawa, Y; Kirk, K; Kopin, IJ; Lamensdorf, I1
Burke, WJ; Li, SW; Nonneman, R; Williams, EA; Zahm, DS1
Bustamante, D; Herrera-Marschitz, M; Israel, Y; Quintanilla, ME; Tampier, L1
Baranyi, M; Gagov, H; Kalfin, R; Petkova-Kirova, P; Rakovska, A; Windisch, K1

Other Studies

4 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and homovanillic acid

ArticleYear
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde.
    Journal of neuroscience research, 2000, May-15, Volume: 60, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Differentiation; Cell Line; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Electron Transport; Glucose; Homovanillic Acid; Humans; L-Lactate Dehydrogenase; Mitochondria; Nerve Growth Factor; Neurons; Neurotoxins; Oxidation-Reduction; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone; Stress, Physiological; Uncoupling Agents

2000
3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
    Brain research, 2003, Nov-07, Volume: 989, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Homovanillic Acid; Immunohistochemistry; Male; Neurons; Parkinson Disease; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area

2003
Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
    European journal of pharmacology, 2007, Nov-14, Volume: 573, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Alcoholism; Anesthesia, Inhalation; Animals; Breeding; Chromatography, High Pressure Liquid; Dextroamphetamine; Dopamine; Female; Genetic Predisposition to Disease; Homovanillic Acid; Hydroxyindoleacetic Acid; Isoflurane; Male; Microdialysis; Nucleus Accumbens; Potassium Chloride; Rats; Rats, Inbred Strains; Serotonin; Stereotaxic Techniques

2007
Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Brain research bulletin, 2017, Volume: 134

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Electric Stimulation; Extracellular Space; Homovanillic Acid; Humans; Male; Mice; Nerve Tissue Proteins; Norepinephrine; Nucleus Accumbens; Peptide Fragments; Phenylethyl Alcohol; Reward; Tissue Culture Techniques

2017